These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 10334298)
1. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma. Wang M; Wise SC; Leff T; Su TZ Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298 [TBL] [Abstract][Full Text] [Related]
2. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression. Brunmair B; Gras F; Neschen S; Roden M; Wagner L; Waldhäusl W; Fürnsinn C Diabetes; 2001 Oct; 50(10):2309-15. PubMed ID: 11574413 [TBL] [Abstract][Full Text] [Related]
3. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869 [TBL] [Abstract][Full Text] [Related]
5. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190 [TBL] [Abstract][Full Text] [Related]
6. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Aoun P; Simpkins JW; Agarwal N Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244 [TBL] [Abstract][Full Text] [Related]
7. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity. Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610 [TBL] [Abstract][Full Text] [Related]
8. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. Baek SJ; Wilson LC; Hsi LC; Eling TE J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986 [TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes. Kasai K; Banba N; Hishinuma A; Matsumura M; Kakishita H; Matsumura M; Motohashi S; Sato N; Hattori Y Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1859-69. PubMed ID: 11078701 [TBL] [Abstract][Full Text] [Related]
10. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617 [TBL] [Abstract][Full Text] [Related]
11. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. Ruan H; Pownall HJ; Lodish HF J Biol Chem; 2003 Jul; 278(30):28181-92. PubMed ID: 12732648 [TBL] [Abstract][Full Text] [Related]
12. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343 [TBL] [Abstract][Full Text] [Related]
13. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. Masamune A; Kikuta K; Satoh M; Sakai Y; Satoh A; Shimosegawa T J Biol Chem; 2002 Jan; 277(1):141-7. PubMed ID: 11606585 [TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level. Bakopanos E; Silva JE Diabetes; 2000 Dec; 49(12):2108-15. PubMed ID: 11118014 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands. Rumi MA; Sato H; Ishihara S; Ortega C; Kadowaki Y; Kinoshita Y J Lab Clin Med; 2002 Jul; 140(1):17-26. PubMed ID: 12080324 [TBL] [Abstract][Full Text] [Related]
17. Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism. Hilding A; Hall K; Skogsberg J; Ehrenborg E; Lewitt MS Biochem Biophys Res Commun; 2003 Apr; 303(2):693-9. PubMed ID: 12659874 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. Padilla J; Kaur K; Cao HJ; Smith TJ; Phipps RP J Immunol; 2000 Dec; 165(12):6941-8. PubMed ID: 11120820 [TBL] [Abstract][Full Text] [Related]
19. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]